| |
|
Form Serial Number: |
DA20220308E00039
|
| 1.
Date of relevant event: |
03/03/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02190 |
| 4.
Name of listed corporation: |
歸創通橋醫療科技股份有限公司 - B - H股 |
| 5.
Class of shares: |
Domestic Shares |
| 6.
Number of issued shares in class: |
7,781,257 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
XIE |
| (Other names) |
YANG |
|
|
|
| 10.
Name of director (Chinese): |
谢阳 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
14,251,425 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 16,002,516 | 7.93 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 1,751,091 | 22.50 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| | | | | CNY | 2.130 | | | 167,599 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 珠海通桥投资中心（有限合伙） | 珠海市横琴新区宝华路6号105室-20266（集中办公区） | 谢阳 | 36.36 | Y | |
| 杭州涪江投资合伙企业（有限合伙） | 杭州市余杭区余杭街道科技大道18号1幢201室 | 谢阳 | 46.02 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
表格24及27：(1) 谢阳先生为公司董事，其作为实益拥有人的权益为其根据首次公开发售前购股权计划获授予的购股权，共计有权收取最多167,599股内资股，前提是遵守该等购股权的条件（包括归属条件）。(2) 谢阳先生通过表格30中其所控制的法团于1583492股内资股中拥有权益
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
08/03/2022
(dd/mm/yyyy)
|
| |